October 15, 2024

New Member: Welcome in our cluster to !LEVA Sciences GmbH

New Member: Welcome in our cluster to !LEVA Sciences GmbH
Go back

!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded to share this expertise with innovative life science projects, helping companies achieve success through hands-on involvement and C-level leadership when needed.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
Hummingbird Diagnostics Showcases New Data Utilizing Blood-Based Small RNA for Lung Cancer Treatment Monitoring at ESMO Congress 2026

Hummingbird Diagnostics Showcases New Data Utilizing Blood-Based Small RNA for Lung Cancer Treatment Monitoring at ESMO Congress 2026

Study demonstrates the ability of small RNA to inform lung cancer treatment strategies HEIDELBERG, Germany, October 26, 2026 – Hummingbird Diagnostics GmbH, a pioneer in blood-based small RNA biomarker discovery and assay development, today announced new clinical data demonstrating the ability of small RNA to enable adaptive treatment strategies in lung cancer patients. The results […]

read more
Newsletter der BMBH: Biobanking Update!

Newsletter der BMBH: Biobanking Update!

Informationen über unsere Aktivitäten und aktuelle Entwicklungen im Biobanking am Standort und darüber hinaus. IN DIESER AUSGABE__Die BMBH im ÜberblickAktuelles aus der BMBHAktuelles aus denMitgliedsbiobankenNationale / InternationaleBiobanking-AktivitätenPublikationenAnstehende Termine

read more
Huntington’s Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research

Huntington’s Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research

Proteins to Watch in Huntington’s Disease Research When developing assays to study Huntington’s disease (HD), scientists have a rare advantage: they know the exact genetic cause. But that hasn’t made the biological mechanism any easier to tackle. Despite decades of research, effective treatments remain limited for this progressive degenerative disease.2 HD is inherited in an autosomal-dominant […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp